article · 2011
Zoledronic acid inhibits adjuvant letrozole-associated bone loss in postmenopausal Japanese women with early breast cancer.
9075 Background: The primary analysis at 12 months (12M) of the Z-/ZO-FAST studies demonstrated that the loss of bone mineral density (BMD) could be effectiv...
2 citationsDOI: https://doi.org/10.1200/jco.2011.29.15_suppl.9075